269 related articles for article (PubMed ID: 16778256)
1. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Hursting MJ; Levine RL; Leya F
Chest; 2006 Jun; 129(6):1407-16. PubMed ID: 16778256
[TBL] [Abstract][Full Text] [Related]
2. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
[TBL] [Abstract][Full Text] [Related]
3. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
Bartholomew JR; Pietrangeli CE; Hursting MJ
Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
[TBL] [Abstract][Full Text] [Related]
4. Heparin-induced thrombocytopenia from venous thromboembolism treatment.
Begelman SM; Hursting MJ; Aghababian RV; McCollum D
J Intern Med; 2005 Dec; 258(6):563-72. PubMed ID: 16313480
[TBL] [Abstract][Full Text] [Related]
5. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
[TBL] [Abstract][Full Text] [Related]
6. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Berkowitz SD; Matthai WH; Fareed J; Walenga JM; Bartholomew J; Sham R; Lerner RG; Zeigler ZR; Rustagi PK; Jang IK; Rifkin SD; Moran J; Hursting MJ; Kelton JG;
Circulation; 2001 Apr; 103(14):1838-43. PubMed ID: 11294800
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytopenia following heparin flush.
McNulty I; Katz E; Kim KY
Prog Cardiovasc Nurs; 2005; 20(4):143-7. PubMed ID: 16276136
[TBL] [Abstract][Full Text] [Related]
8. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
Levine RL; Hursting MJ; McCollum D
Chest; 2006 May; 129(5):1167-75. PubMed ID: 16685006
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
Murray PT; Hursting MJ
Ren Fail; 2006; 28(7):537-9. PubMed ID: 17050234
[TBL] [Abstract][Full Text] [Related]
10. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
[TBL] [Abstract][Full Text] [Related]
11. Argatroban therapy in women with heparin-induced thrombocytopenia.
Jang IK; Baron SJ; Hursting MJ; Anglade E
J Womens Health (Larchmt); 2007; 16(6):895-901. PubMed ID: 17678460
[TBL] [Abstract][Full Text] [Related]
12. Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
Bartholomew JR; Hursting MJ
J Thromb Thrombolysis; 2005 Jun; 19(3):183-8. PubMed ID: 16082605
[TBL] [Abstract][Full Text] [Related]
13. Identifying patient- and treatment-related factors related to amputation risk in cases of heparin-induced thrombocytopenia treated with argatroban.
Haas S; Lewis B
Int Angiol; 2011 Dec; 30(6):541-6. PubMed ID: 22233615
[TBL] [Abstract][Full Text] [Related]
14. Argatroban in the management of heparin-induced thrombocytopenia.
Babuin L; Pengo V
Vasc Health Risk Manag; 2010 Sep; 6():813-9. PubMed ID: 20859550
[TBL] [Abstract][Full Text] [Related]
15. A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience.
Curzio KM; Cheng-Lai A; Kheyfets V; Sinnet M; Billett HH
J Thromb Thrombolysis; 2009 Aug; 28(2):117-23. PubMed ID: 18827975
[TBL] [Abstract][Full Text] [Related]
16. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
Dhillon S
Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821
[TBL] [Abstract][Full Text] [Related]
17. Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review.
Wang Y; Zhang K; Yin L; Fu G; Liu Z
Ann Vasc Surg; 2022 Mar; 80():392.e1-392.e7. PubMed ID: 34656708
[TBL] [Abstract][Full Text] [Related]
18. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
[TBL] [Abstract][Full Text] [Related]
19. Argatroban therapy in patients with coronary artery disease and heparin-induced thrombocytopenia.
Jang IK; Hursting MJ; McCollum D
Cardiology; 2008; 109(3):172-6. PubMed ID: 17726318
[TBL] [Abstract][Full Text] [Related]
20. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
Hursting MJ; Soffer J
Drug Saf; 2009; 32(3):203-18. PubMed ID: 19338378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
